NDA based on data from global ARROS-1 Phase 1/2 clinical trial FDA assigns PDUFA target action date of September 18, 2026 CAMBRIDGE, Mass., Nov. 19, 2025 ...
Most foreign firms CNA spoke to are forging ahead with long-term business plans in the country, including expansion. Analysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback